TA-1 Complex (Thymosin Alpha-1 | Thymalin) 10/6 mg

Now Shipping: Batch TA1C25-16-002 | Thymosin Alpha-1 11.45 mg | Thymalin 7.41 mg

The product is a blend of Thymosin Alpha-1 and Thymalin

Appearance: white powder
Storage: 2-8°
Purity: ≥99%

Thymosin Alpha-1
CAS NO: 62304-98-7
Molecular Formula: C₁₂₉H₂₁₅N₃₃O₅₅
Molecular Weight: 3108.32 g/mol

Thymalin
CAS NO: 63958-90-7
Molecular Formula: C33H54N12O15
Molecular Weight: 858.85 g/mol

The research potential for a peptide blend of Thymosin Alpha-1 and Thymalin has application within the realms of immunology and regenerative medicine. Both peptides are known for their effects on the immune system, each acting through distinct yet potentially complementary mechanisms. This blend represents an innovative approach to modulating immune responses, with implications for researching treatment for a wide array of diseases, including infections and autoimmune disorders.

Thymosin Alpha-1 is a peptide derived from the thymus gland, known for its ability to enhance T-cell function, stimulate immune cell differentiation, and modulate cytokine production. Its clinical applications have included treatments for viral infections, immunodeficiencies, and as an adjunct in cancer therapy, leveraging its capacity to bolster the immune response.

Thymalin, another thymus-derived peptide, plays a crucial role in regulating the immune system and homeostasis. It has been shown to normalize T-cell function, stimulate regenerative processes, and has potential anti-inflammatory effects. Thymalin’s actions in modulating immune balance make it a candidate for addressing age-related declines in immune function and for therapies aimed at autoimmune and inflammatory conditions.

The combination of Thymosin Alpha-1 and Thymalin in a single blend offers a novel research avenue with several potential benefits:

Synergistic Immunomodulation: This blend could provide a synergistic effect on the immune system, enhancing both the innate and adaptive immune responses. The combined action on T-cell maturation, differentiation, and regulatory balance may offer a more comprehensive immunomodulatory therapy.

Enhanced Regenerative Potential: Given Thymalin’s role in stimulating regenerative processes and Thymosin Alpha-1’s ability to enhance immune response, this blend could have significant implications for wound healing, tissue repair, and possibly organ regeneration.

Broad Therapeutic Applications: The blend’s potential in modulating immune function suggests a wide range of therapeutic applications, from infectious diseases and vaccines to autoimmune conditions.

Aging and Longevity: The potential for this blend to modulate immune senescence could have significant implications for aging research, offering a strategy to counteract the decline in immune function associated with aging, thereby improving healthspan and resistance to age-related diseases.

Please note that all products featured here are intended exclusively for research and development purposes. They are not designed for any form of human consumption. These products have not undergone evaluation by the U.S. Food and Drug Administration.